For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. Read more
Medical News - Nov 27
A precise timing of existing treatments could significantly improve treatment outcomes for one of the most aggressive cancers, suggests new research from researchers at UC San Diego. Read more
Uc San Diego Today - Nov 26
(MedPage Today) -- DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed a high-fiber diet, a small prospective study showed.During a median follow-up of 17 months, patients... Read more
Medpagetoday - Nov 16
The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to cancer. But when p53 mutates, it can flip from protector to promoter of cancer. Read more
Medical Xpress - Nov 05
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential strategy to prevent or reverse that resistance. Read more
Medical News - Oct 31
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two Read more
Medical News - Oct 29
The same cell therapy could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers. Read more
University Of California, Los Angeles - Oct 21
Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Equity Insider News Commentary – MIT and Harvard scientists recently created engineered CAR-NK cells that hide from the immune system and more effectively destroy cancer, opening doors... Read more
Benzinga - Oct 17
